From the *Centers for Disease Control and Prevention, The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, GA; and †Department of Preventive Medicine and Public Health, University of Kansas Medical School, Kansas City, KS
Acknowledgments: The authors thank the following individuals for providing expertise and feedback during the development of this manuscript: Harrell Chesson, PhD; Sarah Gerver, PhD, MSc; Susan Hariri, PhD; Brooke Hoots, PhD, MSPH; Sarah Kidd, MD, MPH; Robert Kirkcaldy, MD, MPH; Lauri Markowitz, MD; Thomas Peterman, MD, MSc; Henry Roberts, PhD; and Mark Stenger, MA. Without the support and data provided by state and local health departments that conduct HIV, sexually transmitted disease/sexually transmitted infection, and viral hepatitis surveillance, as well as those that conduct HIV incidence surveillance, this manuscript would not have been possible.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Conflicts of interest and source of funding: None declared.
Correspondence: Catherine Lindsey Satterwhite, PhD, MSPH, MPH, Division of STD Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Mailstop E80, Atlanta, GA 30333. E-mail: [email protected].
Received for publication June 12, 2012, and accepted November 21, 2012.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (http://www.stdjournal.com).
